A synthetic peptide for use as a blocking control in assays to test for specificity of EGLN3 antibody, Alternative Names: EGLN3 control peptide, EGLN3 antibody Blocking Peptide, Anti-EGLN3 Blocking Peptide, Egl Nine Homolog 3 Blocking Peptide, FLJ21620 Blocking Peptide, HIFPH3 Blocking Peptide, MGC125998 Blocking Peptide, MGC125999 Blocking Peptide, PHD3 Blocking Peptide
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Antigène
EGLN3
(Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
Sujet
EGLN3 catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. It hydroxylates HIF-1 alpha at 'Pro-564', and HIF-2 alpha. EGLN3 functions as a cellular oxygen sensor and, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. It may play a role in cell growth regulation in muscle cells and in apoptosis in neuronal tissue. EGLN3 promotes cell death through a caspase-dependent mechanism.